banner Support Products My Account Home

June 6, 2006 — Issue No. 60


 

In This Issue

Recent Clinical Updates

Clinical UpdatesIn May, the Medical Information editors updated 196 drug monographs and added 9 new drug monographs, including:

  • amyl nitrite/sodium nitrite/sodium thiosulfate (Cyanide Antidote Package)
  • betamethasone dipropionate/calcipotriene (Taclonex)
  • caffeine/sodium benzoate (generic)
  • calcitonin-salmon recombinant (Fortical)
  • cilostazol (generic)
  • diazoxide (Proglycem)
  • ranolazine (Ranexa)
  • pravastatin (generic)
  • somatropin (Tev-Tropin)

Link Your EMR to Epocrates

Linx Would you like to access Epocrates information from your electronic medical records system?

When an EMR is linked to Epocrates mobile or online drug references via Epocrates Linx technology, you can easily go from a patient record to an Epocrates drug monograph and back again.

Epocrates Linx also integrates Epocrates information with e-prescribing, practice management, lab, and billing systems.


 

New DocAlert Content Sources

Caduceus The Epocrates DocAlert editors continually look for new sources of timely, clinically useful information for our members.

Our newest DocAlert partners include:

  • InfoPOEMs — evidence-based medicine (“Patient-Oriented Evidence that Matters”)
  • Journal Watch — commentary and evidence-based medicine

Information about our DocAlert content sources, editorial process, and policy regarding DocAlerts that are sponsored by commercial organizations such as pharmaceutical companies, is available on our website.

New ACLS and PALS Guidelines

HeartThe ACLS and PALS tables in Epocrates Essentials, Epocrates Rx Pro, and Epocrates Online premium have been updated to reflect the 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.

Updates include:

  • New ACLS table for basic life support
  • New NALS/NRP table for neonatal resuscitation
  • Revisions to 14 drug monographs incorporating specific dosing recommendations for ACLS/PALS

Mobile Users: AutoUpdate to receive these updates.

 

 

Quick Poll

Which of the following is your primary drug safety concern?

  • Drug-drug interactions
  • Drug-herbal interactions
  • Adverse reactions
  • Pregnancy and lactation risks
  • Incorrect dosing
  • Lack of patient compliance
  • Dispensing error
  • Administration error

Please note that poll questions can only be answered in the HTML version of our email newsletter.

Last month we asked you at what age you think you will retire.

The majority said 65-69. However, nine percent said "Never!"

 

Tip of the Month

Look up dosage strength and dosage form in the Epocrates drug database

Available strengths and limited dosage form information is provided in an abbreviated format within all Epocrates Rx and Epocrates Online drug monographs. You can look up this information in two monograph sections. 

Epocrates, Inc., 1100 Park Place Suite 300, San Mateo, CA 94403 | www.epocrates.com